Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003159106.
Observations2
Issue DateApril 24, 2026
Status1 Related Warning Letter
Related Inspections5
Establishment Details
Firm
Aspire Pharmaceuticals, Inc.
Location
Somerset, New Jersey
FEI Number
3003159106
Product Type
Drugs
Issue Date
April 24, 2026
Country
United States
Inspection History, 2010 to 2026
NAI1
VAI4
NAI means No Action Indicated. VAI means Voluntary Action Indicated.